Enzo Biochem, Inc. (ENZ) Widens Q4 Loss to 69c/Share
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Foreign currency gain (loss): -361K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Foreign currency gain (loss): -361K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q4 EPS of ($0.69), versus ($0.11) reported last year. Revenue for the quarter came in at $26.4 million, versus $26.8 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS
- Immucell Corp (ICCC) Reports Q2 EPS of $0.20
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
